Search research articles
Contact Us
Filters
Showing results (101-110 of 132) with videos related to
Page
of 14
Sort By:
Annals of Neurology
|
June 29, 2016
Seed-competent high-molecular-weight tau species accumulates in the cerebrospinal fluid of Alzheimer's disease mouse model and human patients
Shuko Takeda, Caitlin Commins, Sarah L DeVos, et al.
Neurology
|
June 17, 2020
β-Glucocerebrosidase activity in <i>GBA</i>-linked Parkinson disease: The type of mutation matters
Young Eun Huh, Ming Sum Ruby Chiang, Joseph J Locascio, et al.
Biorxiv : the Preprint Server for Biology
|
August 26, 2024
Experimental and Computational Methods for Allelic Imbalance Analysis from Single-Nucleus RNA-seq Data
Sean K Simmons, Xian Adiconis, Nathan Haywood, et al.
Science (New York, N.Y.)
|
September 2, 2017
β2-Adrenoreceptor is a regulator of the α-synuclein gene driving risk of Parkinson's disease
Shuchi Mittal, Kjetil Bjørnevik, Doo Soon Im, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
October 8, 2015
The NINDS Parkinson's disease biomarkers program
Liana S Rosenthal, Daniel Drake, Roy N Alcalay, et al.
Frontiers in Neurology
|
March 20, 2023
Plasma biomarkers for diagnosis of Alzheimer's disease and prediction of cognitive decline in individuals with mild cognitive impairment
Pia Kivisäkk, Becky C Carlyle, Thadryan Sweeney, et al.
Ebiomedicine
|
May 30, 2025
Impact of Y chromosome loss on the risk of Parkinson's disease and progression
Junhao Wang, Xinyi Chen, Wenxuan Du, et al.
Genome Biology
|
April 11, 2026
Experimental and computational methods for allelic imbalance analysis from single-nucleus RNA-seq data
Sean K Simmons, Xian Adiconis, Nathan Haywood, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
February 6, 2021
The Mutation Matters: CSF Profiles of GCase, Sphingolipids, α-Synuclein in PD<sub>GBA</sub>
Stefanie Lerche, Claudia Schulte, Isabel Wurster, et al.
Neurology
|
September 27, 2013
Unrecognized vitamin D3 deficiency is common in Parkinson disease: Harvard Biomarker Study
Hongliu Ding, Kaltra Dhima, Kaitlin C Lockhart, et al.
Page
of 14
Search research articles
Search
Showing results (101-110 of 132) with videos related to
Sort By:
Page
of 14
Annals of Neurology
|
June 29, 2016
Seed-competent high-molecular-weight tau species accumulates in the cerebrospinal fluid of Alzheimer's disease mouse model and human patients
Shuko Takeda, Caitlin Commins, Sarah L DeVos, et al.
Neurology
|
June 17, 2020
β-Glucocerebrosidase activity in <i>GBA</i>-linked Parkinson disease: The type of mutation matters
Young Eun Huh, Ming Sum Ruby Chiang, Joseph J Locascio, et al.
Biorxiv : the Preprint Server for Biology
|
August 26, 2024
Experimental and Computational Methods for Allelic Imbalance Analysis from Single-Nucleus RNA-seq Data
Sean K Simmons, Xian Adiconis, Nathan Haywood, et al.
Science (New York, N.Y.)
|
September 2, 2017
β2-Adrenoreceptor is a regulator of the α-synuclein gene driving risk of Parkinson's disease
Shuchi Mittal, Kjetil Bjørnevik, Doo Soon Im, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
October 8, 2015
The NINDS Parkinson's disease biomarkers program
Liana S Rosenthal, Daniel Drake, Roy N Alcalay, et al.
Frontiers in Neurology
|
March 20, 2023
Plasma biomarkers for diagnosis of Alzheimer's disease and prediction of cognitive decline in individuals with mild cognitive impairment
Pia Kivisäkk, Becky C Carlyle, Thadryan Sweeney, et al.
Ebiomedicine
|
May 30, 2025
Impact of Y chromosome loss on the risk of Parkinson's disease and progression
Junhao Wang, Xinyi Chen, Wenxuan Du, et al.
Genome Biology
|
April 11, 2026
Experimental and computational methods for allelic imbalance analysis from single-nucleus RNA-seq data
Sean K Simmons, Xian Adiconis, Nathan Haywood, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
February 6, 2021
The Mutation Matters: CSF Profiles of GCase, Sphingolipids, α-Synuclein in PD<sub>GBA</sub>
Stefanie Lerche, Claudia Schulte, Isabel Wurster, et al.
Neurology
|
September 27, 2013
Unrecognized vitamin D3 deficiency is common in Parkinson disease: Harvard Biomarker Study
Hongliu Ding, Kaltra Dhima, Kaitlin C Lockhart, et al.
Page
of 14